glp-1 long-term side effects negative Addressing patient concerns about the 'newness' and safety of GLP- 1 receptor agonists: A clinician's guide to counseling Ozempic face (and other GLP-1

J Neurochem 169:e70175

Possible Side Effects Ipamorelin is generally well-tolerated in preclinical and limited human research studies, with a favorable safety profile compared to earlier growth hormone releasing peptides

Currently, Saxenda (Liraglutide - NVO) and Wegovy (Semaglutide - NVO) are the two GLP-1 drugs approved for weight loss by the FDA

Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties

What Is a B12 Shot Package